There is considerable evidence that opening the mitochondrial ATP-sensitive
potassium channel (mitoK(ATP)) is cardioprotective in ischemia-reperfusion
. Two prominent questions surround the role of mitoK(ATP) in the cardiomyoc
yte: How does opening mitoK(ATP) protect? What is the normal physiological
role of mitoK(ATP) in the heart? Before these questions can be addressed, i
t is necessary to agree on the bioenergetic consequences of opening mitoK(A
TP) and this distills down to a single question - does opening mitoK(ATP) c
ause significant uncoupling or not? The evidence strongly indicates that it
does not and that reports of uncoupling and inhibition of Ca2+ uptake are
the result of using toxic concentrations of K-ATP channel openers. Thus, op
ening mitoK(ATP) results in increased K+ flux that is sufficient to change
mitochondrial volume but is insufficient to cause significant depolarizatio
n of membrane potential. The volume changes, however, have significant bioe
nergetic consequences for energy coupling in the cell.